Article Dans Une Revue Nature Communications Année : 2020

Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis

Daniel Jutzi
Ralf Schmidt
  • Fonction : Auteur
Stefan Reber
  • Fonction : Auteur
Jonas Mechtersheimer
  • Fonction : Auteur
Foivos Gypas
Christoph Schweingruber
Martino Colombo
  • Fonction : Auteur
Christine von Schroetter
  • Fonction : Auteur
Fionna Loughlin
  • Fonction : Auteur
Anny Devoy
Eva Hedlund
Mihaela Zavolan
Frédéric H.-T. Allain
  • Fonction : Auteur
Marc-David Ruepp

Résumé

Abstract Mutations in the RNA-binding protein Fused in Sarcoma (FUS) cause early-onset amyotrophic lateral sclerosis (ALS). However, a detailed understanding of central RNA targets of FUS and their implications for disease remain elusive. Here, we use a unique blend of crosslinking and immunoprecipitation (CLIP) and NMR spectroscopy to identify and characterise physiological and pathological RNA targets of FUS. We find that U1 snRNA is the primary RNA target of FUS via its interaction with stem-loop 3 and provide atomic details of this RNA-mediated mode of interaction with the U1 snRNP. Furthermore, we show that ALS-associated FUS aberrantly contacts U1 snRNA at the Sm site with its zinc finger and traps snRNP biogenesis intermediates in human and murine motor neurons. Altogether, we present molecular insights into a FUS toxic gain-of-function involving direct and aberrant RNA-binding and strengthen the link between two motor neuron diseases, ALS and spinal muscular atrophy (SMA).

Fichier non déposé

Dates et versions

hal-04576204 , version 1 (15-05-2024)

Identifiants

Citer

Daniel Jutzi, Sébastien Campagne, Ralf Schmidt, Stefan Reber, Jonas Mechtersheimer, et al.. Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis. Nature Communications, 2020, 11 (1), pp.6341. ⟨10.1038/s41467-020-20191-3⟩. ⟨hal-04576204⟩
38 Consultations
0 Téléchargements

Altmetric

Partager

  • More